Cargando…
Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372627/ https://www.ncbi.nlm.nih.gov/pubmed/34019644 http://dx.doi.org/10.1210/clinem/dgab363 |
| _version_ | 1783739821087260672 |
|---|---|
| author | Soccio, Raymond E |
| author_facet | Soccio, Raymond E |
| author_sort | Soccio, Raymond E |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8372627 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83726272021-08-20 Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker? Soccio, Raymond E J Clin Endocrinol Metab Online Only Articles Oxford University Press 2021-05-21 /pmc/articles/PMC8372627/ /pubmed/34019644 http://dx.doi.org/10.1210/clinem/dgab363 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Online Only Articles Soccio, Raymond E Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker? |
| title | Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker? |
| title_full | Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker? |
| title_fullStr | Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker? |
| title_full_unstemmed | Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker? |
| title_short | Galectin-3 in NAFLD: Therapeutic Target or Noncausal Biomarker? |
| title_sort | galectin-3 in nafld: therapeutic target or noncausal biomarker? |
| topic | Online Only Articles |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372627/ https://www.ncbi.nlm.nih.gov/pubmed/34019644 http://dx.doi.org/10.1210/clinem/dgab363 |
| work_keys_str_mv | AT soccioraymonde galectin3innafldtherapeutictargetornoncausalbiomarker |